Samanta Freire results 2
· Newest (Page 1/1, per page 25)
Author: Samanta Freire ×Clear All Filters
Search Results
Purpose To evaluate the different present and future therapeutic β-lactam/β-lactamase inhibitor (BL/BLI) alternatives, namely aztreonam-avibactam, imipenem-relebactam, meropenem-vaborbactam, cefepime-zidebactam, cefepime-taniborbactam, meropenem-nacubactam, and sulbactam-durlobactam against clinical isolates showing reduced susceptibility or resistance to cefiderocol in Enterobacterales, Acinetobacter baumannii , and Pseudomon...
Previous1Next